Carcinoma, squamous cell Clinical Trials
Conditions / Carcinoma, squamous cell
Delta Trials catalogs 88 clinical trials for Carcinoma, squamous cell in its publicly accessible dataset. Within this set, 13 currently recruiting participants and 36 trials have reached completion. This research occurs across 790 participating sites around the world. An additional 39 trials are in other active phases such as not yet recruiting or pending status. Since 2020, 19 trials were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.
Trial Status
88
Total Trials
13
Recruiting
36
Completed
39
Other Active
19
Terminated since 2020
790
Study Locations
Browse by location (790 total)
- Chapel Hill, United States 10 trialsAll trials in Chapel Hill, United States
- Boston, United States 10 trialsAll trials in Boston, United States
- Barcelona, Spain 8 trialsAll trials in Barcelona, Spain
- Madrid, Spain 8 trialsAll trials in Madrid, Spain
- São Paulo, Brazil 7 trialsAll trials in São Paulo, Brazil
- São Paulo, Brazil 7 trialsAll trials in São Paulo, Brazil
- Toronto, Canada 7 trialsAll trials in Toronto, Canada
- São Paulo, Brazil 7 trialsAll trials in São Paulo, Brazil
- São Paulo, Brazil 7 trialsAll trials in São Paulo, Brazil
- São Paulo, Brazil 7 trialsAll trials in São Paulo, Brazil
- São Paulo, Brazil 7 trialsAll trials in São Paulo, Brazil
- Chicago, United States 7 trialsAll trials in Chicago, United States
- São Paulo, Brazil 7 trialsAll trials in São Paulo, Brazil
- Houston, United States 7 trialsAll trials in Houston, United States
- Lille, France 7 trialsAll trials in Lille, France
- São Paulo, Brazil 7 trialsAll trials in São Paulo, Brazil
- Brussels, Belgium 7 trialsAll trials in Brussels, Belgium
- Los Angeles, United States 7 trialsAll trials in Los Angeles, United States
- Portland, United States 6 trialsAll trials in Portland, United States
- New York, United States 6 trialsAll trials in New York, United States